A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV- infected individuals with occult HBV infection

Journal of Viral Hepatitis

Volumn 20, Issue 1, 2013, Pages 42-49

  Cassini, R ^a   De Mitri, M S ^a   Gibellini, D ^a   Urbinati, L ^a   Bagaglio, S ^b   Morsica, G ^b   Domenicali, M ^a   Verucchi, G ^a   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

HIV; liver; occult HBV; PBMC

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOP CODON; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIRUS REPLICATION;

EID: 84870977400     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2012.01623.x     Document Type: Article

References (39)

1. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini- Bréchot P,. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult" ? Hepatology 2001; 34: 194-211.
2. Chemin I, Trepo C,. Clinical impact of occult HBV infections. J Clin Virol 2005; 43: S15-S21.
3. Mulrooney- Cousins PM, Michalak TI,. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. Word J Gastroenterol 2007; 13: 5682-5686.
4. De Mitri MS, Morsica G, Cassini R, et al. Low replication and variability of HBV pre- core in concomitant infection with hepatitis B and hepatitis C viruses. Arch Virol 2007; 152: 395-404.
5. Weinberger KM, Bauer T, Bohom S, Jilg W,. High genetic variability of the group- specific a- determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-1174.
6. Tang H, Delgermaa L, Huang F, et al. The transcriptional function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005; 79: 5548-5556.
7. Tong SP, Li JS, Vitviski L, Trépo C,. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology 1992; 191: 237-245.
8. Hu KQ,. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9: 243-257.
9. Filippini P, Coppola N, Pisapia R, et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 2006; 20: 1253-1260.
10. Nunez M, Rios P, Perez- Olmeda M, Soriano V,. Lack of "occult" hepatitis B virus infection in HIV- infected patients. AIDS 2002; 16: 2099-2101.
11. Santos E, Yoshida CF, Rolla VC, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Microbiol Infect Dis 2003; 22: 92-98.
12. Romet- Lemonne JP, McLane MF, Elfassi E, Haseltine WA, Azocar J, Essex M,. Hepatitis B virus infection in cultured human lymphoblastiod cells. Science 1983; 221: 667-669.
13. Stoll- Becker S, Repp R, Glebe D, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol 1997; 71: 5399-5407.
14. Kock J, Theilmann L, Galle P, Schlicht HJ,. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicative virus. Hepatology 1996; 23: 405-413.
15. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5: 431-433.
16. De Mitri MS, Poussin K, Baccarini P, et al. HCV- associated liver cancer without cirrhosis. Lancet 1995; 345: 413-415.
17. Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, Re MC,. Quantitative detection of human immunodeficiency virus type 1 (HIV- 1) proviral DNA in peripheral blood mononuclear cells by SYBR green real- time PCR technique. J Clin Virol 2004; 29: 282-289.
18. Brunetto MR, Giarin MM, Olivieri F, et al. Wild type and e antigen- minus hepatitis B virus in course of chronic hepatitis. Proc Natl Acad Sci U S A 1991; 88: 4186-4190.
19. Raffa G, Maimone S, Cargnel A, et al. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. AIDS 2007; 21: 2171-2175.
20. Fabris P, Biasin MR, Giordani MT, et al. Impact of occult HBV infection in HIV/HCV co- infected patients: HBV- DNA detection in liver specimens and in serum samples. Curr HIV Res 2008; 6: 173-179.
21. Zehender G, De Maddalena C, Milazzo L, et al. Hepatitis B virus genotype distribution in HIV coinfected patients. Gastroenterology 2003; 125: 1559-1560.
22. Sagnelli E, Imparato M, Coppola N, et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicentric study. J Med Virol 2008; 80: 1547-1553.
23. Rodriguez- Inigo E, Mariscal L, Bartolomè J, et al. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection. J Med Virol 2003; 70: 571-580.
24. Bellini C, Keiser O, Chave JP, et al. Liver enzyme elevation after lamivudine withdrawal in HIV- hepatitis B virus co- infected patients: the Swiss HIV Cohort Study. HIV Med 2009; 10: 12-18.
25. Bagaglio S, Porrino L, Lazzarin A, Morsica G,. Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV infected person with reactivation of HBV after antiretroviral treatment interruption. Infection 2010; 38: 417-421.
26. Sugauchi F, Tanaka Y, Kusumoto S, et al. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. J Med Virol 2011; 83: 412-418.
27. Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg- negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68. Erratum in: Gastroenterology 2006; 131:1363.
28. Coffin CS, Mulrooney- Cousins PM, Peters MG, et al. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat 2011; 18: 415-423.
29. Cheng PN, Liu WC, Tsai HW, Chang TT, Young KC,. Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents. J Med Virol 2011; 83: 602-607.
30. Gilson RJC, Hawkins AE, Beecham MR, et al. Interaction between HIV and hepatitis B virus in homosexual men; effects on the natural history of infection. AIDS 1997; 11: 597-606.
31. Alter MJ,. Epidemiology of viral hepatitis and HIV co- infection. J Hepatol 2006; 44: S6-S9.
32. Morsica G, Bagaglio S, Cicconi P, et al. Viral interference between hepatitis B, C, D viruses in dual and triple infections in HIV- positive patients. J Aquir Immune Defic Syndr 2009; 51: 574-581.
33. Crespo J, Lozano JL, Carte B, de las Heras B, de la Cruz F, Pons- Romero F,. Viral replication in patients with concomitant hepatitis B and C virus infection. Eur J Clin Microbiol Infec Dis 1997; 16: 445-451.
34. De Mitri MS, Cassini R, Morsica G, et al. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV- related hepatocellular carcinoma. J Viral Hepat 2006; 13: 574-581.
35. Shih CM, Lo SJ, Mijamura T, Chen SY, Lee YH,. Suppression of hepatitis B virus expression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH- 7 cells. J Virol 1993; 67: 5823-5832.
36. Chandhuri V, Tayal R, Nayak B, Acharya SK, Panda SK,. Occult hepatitis B virus infection in chronic liver disease: full- length genome and analysis of mutant surface promoter. Gastroenterology 2004; 127: 1356-1371.
37. Grethe S, Monazahian M, Bohme I, Thomssen R,. Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen- negative subjects. J Virol 1998; 72: 7692-7696.
38. Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C,. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 1999; 180: 1444-1451.
39. Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen- negative Chinese carriers. Hepatology 2001; 34: 1027-1034.